Among breast and colorectal cancer survivors, randomization to 12 weeks of aerobic exercise increased LIF and IL‐15, whereas randomization to 12 weeks of metformin reduced apelin and IL‐15. The gene discussed is LIF; the disease is colorectal cancer.